Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,284,664 papers from all fields of science
Search
Sign In
Create Free Account
laropiprant
Known as:
(-)-((3R)-4-(4-Chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic Acid
A prostaglandin D2 receptor (DP1) antagonist with niacin-induced vasodilation inhibiting activity. Laropiprant binds to and inhibits the activity of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
MK-0524
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Synthesis and biological evaluation of novel laropiprant derivatives as potential anti-allergic agents
Haiping Zhou
,
Qihua Zhu
,
Z. Gan
,
Guangping Dong
,
Yungen Xu
Medicinal Chemistry Research
2015
Corpus ID: 253637935
DP antagonists are claimed to be useful in the treatment of allergic disorders. Laropiprant is a potent and selective DP…
Expand
2014
2014
Niacin-laropiprant adjunct to statin therapy poses risks to heart patients, study says
J. Talsma
2014
Corpus ID: 74296643
Patients who received the combo along with statin therapy did not experience higher rates of prevention of major vascular events…
Expand
2012
2012
laropiprant combination of doxycycline for the treatment of rosacea
C. Rosignoli
,
J. Fournier
,
J. Aubert
2012
Corpus ID: 80247010
The invention relates to a pharmaceutical composition, especially dermatological composition, comprising laropiprant, ester or a…
Expand
2012
2012
Tredaptive ® : extended-release niacin with laropiprant
J. V. Schoor
2012
Corpus ID: 93742874
Tredaptive ® tablets contain 1 g extended-release niacin (nicotinic acid) with 20 mg immediate-release laropiprant. 1 The product…
Expand
2012
2012
laropiprant combination and ivermectin for the treatment of rosacea
C. Rosignoli
,
J. Fournier
,
J. Aubert
2012
Corpus ID: 108902539
L'invention a pour objet une composition pharmaceutique, notamment dermatologique, comprenant du laropiprant, un ester ou un sel…
Expand
2010
2010
Triumph of the heart: The story of statins
P. Libby
2010
Corpus ID: 70925288
Triumph of the heart: the story of statins by Jie Jack Li actually comprises several books in one — threads that run through the…
Expand
2009
2009
RENAISSANCE DE LA NIACINE SOUS UNE NOUVELLE FORME GALÉNIQUE, LE TREDAPTIVE™
O. Descamps
,
M. Hermans
,
A. Persu
2009
Corpus ID: 193440638
L'utilisation de la niacine ou acide nicotinique, - un anti-dyslipidemiant connu de longue date au profil original - a longtemps…
Expand
Review
2009
Review
2009
Niacin Laropiprant combination in the management of dyslipidemia: a novel pharmaceutical formulation.
S. Kalra
,
P. Batra
,
B. Kalra
,
Amit Sharma
,
Ashraf Ganie
2009
Corpus ID: 55410911
This review describes a novel combination of niacin with laropiprant, which helps improve the tolerability of niacin, which helps…
Expand
2008
2008
Extended release (ER)-Nikotinsäure 1 in Kombination mit Laropiprant (einem Prostaglandin-D2-Antagonist): eine neue Alternative bei der Behandlung von Patienten mit tiefem HDL-Cholesterin?
G. Noseda
,
Schweiz Mendrisio
2008
Corpus ID: 68505425
Summary Nicotinic acid was discovered more than 50 years ago and is a very effective drug. It lowers the levels of all…
Expand
2008
2008
Gateways to clinical trials. July-August 2008.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2008
Corpus ID: 23111308
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept…
Expand